Projects per year
Personal profile
Education
- 2007 DPhil, Physiology and Genomics, University of Oxford
- 2001 M.S., Department of Pharmacology, National Cheng Kung University
- 1999 B.S., School of Pharmacy, Taipei Medical University
Experience
- 2024.01- Dean, College of Pharmacy, Taipei Medical University
- 2018.05- Professor, Master Program in Applied Molecular Epidemiology, Taipei Medical University
- 2015.08- Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2015.08- Professor, Ph.D Program for Neural Regenerative Medicine, Taipei Medical University
- 2015.08- Professor, Ph.D Program for Clinical Drug Discovery from Botanical Herbs, Taipei Medical University
- 2015.08- Professor, Program for Translational Medicine, Taipei Medical University
- 2015.08- Professor, Master Program in Clinical Genomics and Proteomics, Taipei Medical University
- 2018.01-2023.12 Vice Dean, College of Pharmacy, Taipei Medical University
- 2016.04-2017.04 Secretary General, The Pharmaceutical Society of Taiwan
- 2015.08-2018.04 Associate Professor, Ph.D Program for Translational Medicine, Taipei Medical University
- 2013.08-2015.07 Associate Professor, Ph.D Program for Clinical Drug Discovery from Botanical Herbs, Taipei Medical University
- 2013.08-2015.07 Associate Professor, Ph.D Program for Neural Regenerative Medicine, Taipei Medical University
- 2012.08-2015.07 Associate Professor, School of Pharmacy, Taipei Medical University
- 2012.10-2019.07 Director, Ph.D Program for Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2008.10-2012.07 Assistant Professor, Kaohsiung Medical University
- 2002.09-2003.10 Deputy Administrator, Food and Drug Administration of Taiwan
Research Interests
- Genetic characterization of calcium channel related genes to establish personalized therapy
- Molecular identification for human genetic variants and drug responses
Awards
- 2019 Research Dissertation Award - Excellence Award, Taipei Medical University
Fingerprint
Dive into the research topics where Wei-Chiao Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
T細胞受體基因體、HLA圖譜及功能驗證於癌症免疫療法之整合性分析(1/2)
Chang, W.-C. (PI)
9/1/25 → 8/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
114國家重點領域國際合作聯盟創新課程與人才培育計畫
Chang, W.-C. (PI)
9/1/25 → 8/31/26
Project: A - Government Institution › d - Ministry of Education
-
114大學校院產學合作培育博士級研發人才計畫-新藥研發產業研發博士學位學程
Chang, W.-C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › d - Ministry of Education
-
A New Opportunity for Antibody-Mediated Rejection in Kidney Transplantation–Exploring the Risk Factors and Mechanism with the Immunological Methods: Pharmacogenomics Studies
Chang, W.-C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
利用真實世界數據評估老藥對第二型糖尿病的新療效
Chang, W.-C. (PI)
7/1/25 → 2/28/26
Project: A - Government Institution › b - National Science and Technology Council
-
Wdr4 regulates ribosome biogenesis and intestinal homeostasis via let-7
Kajal, K., Rastegari, E., Wang, W. D., Li, J. C., Chen, C. H., Chou, W. H., Chang, W. C., Lin, T. Y., Tsai, K., Lu, T. M., Venkatachalam, K. & Hsu, H. J., 2026, In: EMBO Reports. 27, 8, p. 1870-1903 34 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Characterization of binding affinity changes of SARS-CoV-2 omicron variant peptides to population-specific HLA
Chang, C. M., Wu, C. J., Shkurnikov, M., Guo, C. L., Huang, W. C., Tonevitsky, A. & Chang, W. C., Dec 2025, In: Journal of Biomedical Science. 32, 1, 44.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Comprehensive analysis of B cell receptor repertoires reveals a distinct lambda light chain landscape in immunoglobulin A nephropathy
Luo, W. T., Kao, C. C., Chang, C. M., Wu, M. Y., Liao, H. N., Ho, S. Y., Tsai, I. L., Chou, S. P., Wu, M. S. & Chang, W. C., Oct 10 2025, In: International Immunopharmacology. 163, 115187.Research output: Contribution to journal › Article › peer-review
Open Access -
Cross-ancestry discovery of genetic risk variants for lean metabolic dysfunction-associated steatotic liver disease
Hsu, S. W., Lin, M. R., Chou, W. H., Wan, Y. J. Y., Kao, W. Y. & Chang, W. C., Dec 2025, In: Cell and Bioscience. 15, 1, 131.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
Evaluating the cost-effectiveness of atezolizumab-bevacizumab in advanced hepatocellular carcinoma: Insights from Taiwan
Chang, T. W., Chang, W. C., Chou, W. H., Chang, W. P. & Kuo, C. N., 2025, In: Journal of Food and Drug Analysis. 33, 2, p. 163-171 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Citations (Scopus)
Datasets
-
MOESM10 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
Tsai, F.-J. (Contributor), Lu, H.-F. (Contributor), Lin, Y.-J. (Creator), Chen, C.-H. (Contributor), Wu, J.-Y. (Contributor), Wong, H.S.-C. (Creator), Chang, W.-C. (Contributor) & Liao, W.-L. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10270412.v1, https://doi.org/10.6084%2Fm9.figshare.10270412.v1
Dataset
-
MOESM1 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
Chen, C.-H. (Contributor), Lin, Y.-J. (Creator), Wu, J.-Y. (Contributor), Liao, W.-L. (Creator), Chang, W.-C. (Contributor), Wong, H.S.-C. (Creator), Lu, H.-F. (Contributor) & Tsai, F.-J. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.10270427.v1, https://doi.org/10.6084%2Fm9.figshare.10270427.v1
Dataset
-
MOESM8 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
Lu, H.-F. (Contributor), Wong, H.S.-C. (Creator), Chang, W.-C. (Contributor), Lin, Y.-J. (Creator), Tsai, F.-J. (Contributor), Wu, J.-Y. (Contributor), Liao, W.-L. (Creator) & Chen, C.-H. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.10270466.v1, https://doi.org/10.6084%2Fm9.figshare.10270466.v1
Dataset
-
MOESM4 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
Chen, C.-H. (Contributor), Lu, H.-F. (Contributor), Liao, W.-L. (Creator), Wong, H.S.-C. (Creator), Wu, J.-Y. (Contributor), Chang, W.-C. (Contributor), Lin, Y.-J. (Creator) & Tsai, F.-J. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.10270445.v1, https://doi.org/10.6084%2Fm9.figshare.10270445.v1
Dataset
-
MOESM3 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
Liao, W.-L. (Creator), Chang, W.-C. (Contributor), Wu, J.-Y. (Contributor), Tsai, F.-J. (Contributor), Lin, Y.-J. (Creator), Wong, H.S.-C. (Creator), Chen, C.-H. (Contributor) & Lu, H.-F. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.10270439.v1, https://doi.org/10.6084%2Fm9.figshare.10270439.v1
Dataset